CAR-T Manufacturing: Guidance Anticipates Platform Challenges And Opportunities

 
• By Bowman Cox

Draft from US FDA advises sponsors on how to draw from platform knowledge, while anticipating issues associated with emerging centralized and distributed manufacturing approaches for autologous and allogeneic products and their viral vectors.

CAR-T cells
fast approaching car-t cell therapies • Source: Alamy

More from Manufacturing

More from Compliance